Methods, systems, and devices for sensing, measuring, and controlling closure of a patent foramen ovale
A medical device for reducing the size of a Patent Foramen Ovale is disclosed. The medical device can include a first electrode, a second electrode, and at least one sensor mounted to at least one of the first electrode or the second electrode, the at least one sensor adapted to sense at least one operating parameter of the medical device or the patient to facilitate closure of the Patent Foramen Ovale. The medical device can also include a delivery shaft coupled to the first electrode, wherein the delivery shaft includes an indicia for determining the position of the first electrode relative to the second electrode. A method for determining a characteristic of an internal tissue opening is also disclosed. The method can include the steps of introducing a detectable fluid in the right atrium of a heart and then detecting the location of the detectable fluid in the heart.
1. A method of measuring a characteristic of a patent foramen ovale defining an axis oriented axially through the patent foramen ovale, the method comprising:
extending a distal end of a catheter having a longitudinal length into the patent foramen ovale so that the catheter is oriented longitudinally to be substantially parallel to, or extending substantially along, the axis of the hole;
positioning a first atrial anchor in the left atrium of a heart;
positioning a second atrial anchor in the right atrium of the heart;
releasing a detectable substance directly in the patent foramen ovale from a location between the first atrial anchor and the second atrial anchor and from a port defined in the catheter located proximal the distal end of the catheter; and
detecting the location of the said detectable substance in the heart.
2. The method as recited in claim 1 , wherein said detecting the location of said detectable substance comprises detecting the presence of said detectable substance in the left atrium of the heart.
3. The method as recited in claim 1 , wherein said detectable substance comprises a plurality of bubbles.
4. The method as recited in claim 3 , wherein said plurality of bubbles comprise carbon dioxide.
5. The method as recited in claim 1 , wherein an ultrasonic image facilitates said detecting the location of said detectable substance.
6. The method as recited in claim 1 , wherein said detectable substance comprises saline, saline foam, or a radio opaque contrast solution.
7. The method as recited in claim 1 , wherein said detection of said detectable fluid can enable a user to determine the effectiveness of a heart treatment.
8. The method as recited in claim 1 , wherein said extending comprises positioning a shaft into the patent foramen ovale.
9. A method of measuring a characteristic of a patent foramen ovale defining an axis oriented axially through the patent foramen ovale, the method comprising:
extending a distal portion of a catheter system having a longitudinal length into the patent foramen ovale so that the distal portion of the catheter system is oriented longitudinally to be substantially parallel to, or extending substantially along, the axis of the hole;
positioning a first atrial anchor in the left atrium of a heart;
positioning a second atrial anchor in the right atrium of the heart;
releasing a detectable substance directly in the patent foramen ovale from a location between the first atrial anchor and the second atrial anchor and from a port defined in the catheter system located proximal a distal end of the catheter system; and
detecting the location of the said detectable substance in the heart.
10. The method as recited in claim 9 , wherein said detecting the location of said detectable substance comprises detecting the presence of said detectable substance in the left atrium of the heart.
11. The method as recited in claim 9 , wherein said detectable substance comprises a plurality of bubbles.
12. The method as recited in claim 11 , wherein said plurality of bubbles comprise carbon dioxide.
13. The method as recited in claim 9 , wherein an ultrasonic image facilitates said detecting the location of said detectable substance.
14. The method as recited in claim 9 , wherein said detectable substance comprises saline, saline foam, or a radio opaque contrast solution.
15. The method as recited in claim 9 , wherein said detection of said detectable fluid can enable a user to determine the effectiveness of a heart treatment.
16. The method as recited in claim 9 , wherein said extending comprises positioning a shaft into the patent foramen ovale.